Study name | Citations | Functional imaging agent | Intervention aim | Treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  | Improve standard RTtarget delineation | Facilitate doseescalation | Facilitate organ at risk sparing | Map recurrence & RT treated volumes | Map functional volumes& RT planning volumes | Map treated functionalvolumes & survival | Map radiomic features& RT volumes | Standard treatment | Standard targetvolumes changed | Dose escalation |
Niyazi | F18-FET PET | Â | Â | Â | Â | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â | |
Piroth | F18-FET PET | Â | \(\checkmark\) | Â | \(\checkmark\) | Â | \(\checkmark\) | Â | Â | \(\checkmark\) | \(\checkmark\) | |
Munck Af Rosenschold | F18-FET PET | \(\checkmark\) | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | |
Lundemann | F18-FET PET | \(\checkmark\) | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | \(\checkmark\) | Â | \(\checkmark\) | Â | |
Poulsen | F18-FET PET | \(\checkmark\) | Â | Â | Â | Â | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | |
Harat | [47] | F18-FET PET | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â |
Hayes | [48] | F18-FET PET | \(\checkmark\) | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | Â | \(\checkmark\) | Â |
Fleischmann | [49] | F18-FET PET | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â |
Hirata | C11-MET & F18-FDG PET | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | \(\checkmark\) | Â | \(\checkmark\) | Â | Â | |
Christensen | [57] | C11-AMT PET | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â |
Kosztyla | [58] | F18-FDOPA PET | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â |
Windisch | FAP PET | Â | Â | Â | Â | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â | |
Munshi | [64] | DCE MRI | Â | Â | Â | Â | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â |
Wahl | [65] | DW & DCE MRI | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | \(\checkmark\) | Â | \(\checkmark\) | Â | Â |
Berberat | [69] | DTI MRI | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â |
Altabella | [72] | DTI MRI | Â | Â | \(\checkmark\) | Â | Â | Â | Â | \(\checkmark\) | Â | Â |
Peeken | [73] | DTI MRI | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | \(\checkmark\) | \(\checkmark\) | Â | Â |
Morin | [74] | DW MRI | \(\checkmark\) | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | \(\checkmark\) | Â | Â |
Laprie | MRSI | Â | \(\checkmark\) | Â | Â | Â | Â | Â | Â | Â | \(\checkmark\) | |
Gurbani | [84] | MRSI | Â | Â | Â | \(\checkmark\) | \(\checkmark\) | Â | Â | Â | Â | \(\checkmark\) |
Study name | RT target volume details | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
GTV-S (cm\(^3\)) | GTV-F (cm\(^3\)) | GTV-S+F (cm\(^3\)) | CTV-S (cm\(^3\)) | CTV-F (cm\(^3\)) | CTV-S+F (cm\(^3\)) | PTV-S (cm\(^3\)) | PTV-F (cm\(^3\)) | PTV-S+F (cm\(^3\)) | CTV Target change (%) | PTV Target change (%) | Boost Volume (cm\(^3\)) | |
Niyazi | x 34.1 | x 43.9 | x 48 | x 224.5 | x 240.3 | x 286.8 | x 343.5 | x 356.5 | x 416.5 | x +27.7 | x +21.1 | Â |
Piroth | \(\bar{x}\) 5.2 | \(\bar{x}\) 14.3 | Â | Â | Â | Â | \(\bar{x}\) 219.5 | Â | Â | Â | Â | \(\bar{x}\) 14.3 |
Munck Af Rosenschold | x 37 | x 19.8 | x 38.2 | \(\bar{x}\) 275 | \(\bar{x}\) 290 | \(\bar{x}\) 300 | Â | Â | Â | \(\bar{x}\) +9.1 | Â | Â |
Lundemann | x 33.8 | x 21.4 | x 41.6 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Poulsen | Â | x 21.8 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Harat | Â | x 30.4 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Hayes | Â | Â | Â | x 83.6 | Â | x 94.7 | Â | Â | Â | x +13.3 | Â | Â |
Fleischmann | x 14.0 | x 19.8 | x 30.8 | Â | Â | Â | x 297.8 | Â | x 271.3 | Â | x \(-\)8.9 | Â |
Hirata | x 9.9 | x 60.4 | x 60.4 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Christensen | \(\bar{x}\) 50.2 | \(\bar{x}\) 48.9 | \(\bar{x}\) 67.6 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Kosztyla | \(\bar{x}\) 30.8 | \(\bar{x}\) 58.6 | \(\bar{x}\) 63.5 | \(\bar{x}\) 249 | \(\bar{x}\) 306 | \(\bar{x}\) 312 | \(\bar{x}\) 369 | \(\bar{x}\) 437 | \(\bar{x}\) 445 | \(\bar{x}\) +25.3 | \(\bar{x}\) +20.6 | Â |
Windisch | x 33.8 | x 23.8 - 49.6 | x 60.8 | Â | Â | Â | x 271 | Â | Â | Â | Â | Â |
Munshi | x 40.8 | x 17.2 | x 46.3 | x 200.1 | Â | x 221.0 | x 258 | Â | x 286 | x +10.4 | x +10.8 | Â |
Wahl | \(\bar{x}\) 37.8 | \(\bar{x}\) 21.4 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Berberat | Â | Â | Â | Â | Â | Â | Â | Â | Â | \(-\)50 | \(-\)15 | Â |
Altabella | Â | Â | Â | Â | Â | Â | \(\bar{x}\) 543 | Â | Â | Â | Â | Â |
Peeken | x 23.3 | x 5.9 | Â | x 207.2\(^\alpha\) - 276.8\(^\beta\) | Â | x 240.9 | Â | Â | Â | x -13.0 - +16.3 | Â | Â |
Morin | Â | Â | Â | Â | Â | Â | Â | Â | Â | x -26.7 | Â | Â |
Laprie | Â | Â | Â | Â | Â | Â | Â | Â | x 307.8 | Â | Â | x 97.63 |
Gurbani | Â | 50.6 | Â | Â | Â | Â | Â | Â | Â | Â | Â | \(\le\) 65 |